Market Research Life Sciences Market Research Pharmaceuticals Market Research Drug Delivery Market Research

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 492 Pages GlobalData December, 2023 GBDT18437938
Best Price Guarantee
Price from $4,000
Length 492 Pages
Publisher GlobalData
Published Date December, 2023
SKU GBDT18437938

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Injectable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Injectable Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Injectable Drug Delivery Overview
  • Products under Development
    • Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery - Pipeline Products by Stage of Development
    • Injectable Drug Delivery - Pipeline Products by Segment
      • Table Injectable Drug Delivery - Pipeline Products by Segment
      • Table Injectable Drug Delivery - Pipeline Products by Segment
    • Injectable Drug Delivery - Pipeline Products by Territory
      • Table Injectable Drug Delivery - Pipeline Products by Territory
      • Table Injectable Drug Delivery - Pipeline Products by Territory
    • Injectable Drug Delivery - Pipeline Products by Regulatory Path
      • Table Injectable Drug Delivery - Pipeline Products by Regulatory Path
      • Table Injectable Drug Delivery - Pipeline Products by Regulatory Path
    • Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
    • Injectable Drug Delivery - Ongoing Clinical Trials
      • Table Injectable Drug Delivery - Ongoing Clinical Trials
      • Table Injectable Drug Delivery - Ongoing Clinical Trials
  • Injectable Drug Delivery - Pipeline Products under Development by Companies
    • Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
    • Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Injectable Drug Delivery Companies and Product Overview
    • AcelRx Pharmaceuticals Inc Company Overview
      • AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PFS-01 - Product Status
        • Table PFS-01 - Product Description
        • Table PFS-02 - Product Status
        • Table PFS-02 - Product Description
    • Actuated Medical Inc Company Overview
      • Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OSII - Product Status
        • Table OSII - Product Description
    • Adalvo Company Overview
      • Adalvo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adalvo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Icatibant Pre-Filled Syringe - Product Status
        • Table Icatibant Pre-Filled Syringe - Product Description
    • AdrenaCard, Inc. Company Overview
      • AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adrenacard Auto-Injector - Product Status
        • Table Adrenacard Auto-Injector - Product Description
    • AktiVax Inc. Company Overview
      • AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARAI-2PAM - Product Status
        • Table ARAI-2PAM - Product Description
    • Alexion Pharmaceuticals Inc Company Overview
      • Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ALXN1720 Prefilled Syringe - Product Status
        • Table ALXN1720 Prefilled Syringe - Product Description
        • Table Alexion Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table ALXN1720 Prefilled Syringe - A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
    • Allergan Ltd Company Overview
      • Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NOVADUR Intravitreal Implant - Product Status
        • Table NOVADUR Intravitreal Implant - Product Description
    • Alsensa ApS Company Overview
      • Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table SQJCT - Product Status
        • Table SQJCT - Product Description
    • Alvotech Swiss AG Company Overview
      • Alvotech Swiss AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alvotech Swiss AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table AVT06 - Eylea - Product Status
        • Table AVT06 - Eylea - Product Description
        • Table Alvotech Swiss AG - Ongoing Clinical Trials Overview
        • Table AVT06 - Eylea - Single-arm, Open Label, Multicenter Clinical Study to Evaluate the Handling and Safety of AVT06 Pre-filled Syringe (PFS) in Subjects With Chorioretinal Vascular Disease Followed by an Optional Extension Phase of AVT06 Pre-filled Syringe (PFS)
    • Amneal Pharmaceuticals Inc Company Overview
      • Amneal Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amneal Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dihydroergotamine Autoinjector - Product Status
        • Table Dihydroergotamine Autoinjector - Product Description
    • Antares Pharma Inc Company Overview
      • Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ATRS-1901 Auto-Injector - Product Status
        • Table ATRS-1901 Auto-Injector - Product Description
        • Table Methotrexate Auto Injector - Ectopic Pregnancy - Product Status
        • Table Methotrexate Auto Injector - Ectopic Pregnancy - Product Description
        • Table Rescue Pen - Product Status
        • Table Rescue Pen - Product Description
        • Table Selatogrel Auto-Injector - Product Status
        • Table Selatogrel Auto-Injector - Product Description
        • Table Teriparatide Disposable Pen Injector - Product Status
        • Table Teriparatide Disposable Pen Injector - Product Description
        • Table VAI ATRS-1902 Auto-Injector - Product Status
        • Table VAI ATRS-1902 Auto-Injector - Product Description
        • Table Vibex QS M Auto-Injector - Product Status
        • Table Vibex QS M Auto-Injector - Product Description
        • Table Antares Pharma Inc - Ongoing Clinical Trials Overview
        • Table Selatogrel Auto-Injector - Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Self-administered Subcutaneous Selatogrel for Prevention of All-cause Death and Treatment of Acute Myocardial Infarction in Subjects with a Recent History of Acute Myocardial Infarction
    • Apellis Pharmaceuticals Inc Company Overview
      • Apellis Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apellis Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Empaveli Injector - Product Status
        • Table Empaveli Injector - Product Description
        • Table Apellis Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table Empaveli Injector - An Open Label, Non-randomized, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • ApiJect Systems Corp Company Overview
      • ApiJect Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ApiJect Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prefilled ApiJect Injector - Future Version - Product Status
        • Table Prefilled ApiJect Injector - Future Version - Product Description
        • Table Prefilled ApiJect Injector - Three-part - Product Status
        • Table Prefilled ApiJect Injector - Three-part - Product Description
        • Table Prefilled ApiJect Injector - Two-Part - Product Status
        • Table Prefilled ApiJect Injector - Two-Part - Product Description
    • Aptissen SA Company Overview
      • Aptissen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aptissen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table EVI01 - Product Status
        • Table EVI01 - Product Description
        • Table TID01 - Product Status
        • Table TID01 - Product Description
    • Aquavit Pharmaceuticals Inc Company Overview
      • Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apollo (PITO-001) - Product Status
        • Table Apollo (PITO-001) - Product Description
    • Artemes Technologies, Inc. Company Overview
      • Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artemes Magnetic Injection System - Product Status
        • Table Artemes Magnetic Injection System - Product Description
    • Ascendis Pharma AS Company Overview
      • Ascendis Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascendis Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransCon hGH Auto-Injector - Product Status
        • Table TransCon hGH Auto-Injector - Product Description
        • Table TransCon PTH Pen Injector - Product Status
        • Table TransCon PTH Pen Injector - Product Description
        • Table Ascendis Pharma AS - Ongoing Clinical Trials Overview
        • Table TransCon hGH Auto-Injector - The Efficacy, Safety and Tolerability of TransCon hGH Administered Weekly Versus Daily hGH in Prepubertal Children with Growth Hormone Deficiency: a Randomized, Open-lable, Active-controlled, Parallel-group Study in China
        • Table TransCon PTH Pen Injector - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Trial, with an Open-Label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults with Hypoparathyroidism: PaTHway TRIAL
        • Table TransCon PTH Pen Injector - PaTH Forward: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial with an Open-label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults with Hypoparathyroidism
    • ASCIL Biopharm Company Overview
      • ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASTECH - Product Status
        • Table ASTECH - Product Description
        • Table Combo Connector - Dual Chamber Device - Product Status
        • Table Combo Connector - Dual Chamber Device - Product Description
        • Table DuoLapse - Product Status
        • Table DuoLapse - Product Description
    • Ash Access Technology Inc Company Overview
      • Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zuragen - Product Status
        • Table Zuragen - Product Description
    • ASIS Corp Company Overview
      • ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automatic Subdermal Injection System - Product Status
        • Table Automatic Subdermal Injection System - Product Description
    • Auckland Bioengineering Institute Company Overview
      • Auckland Bioengineering Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auckland Bioengineering Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jet Injection - Product Status
        • Table Jet Injection - Product Description
    • AzureBio SL Company Overview
      • AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Needle - Product Status
        • Table Injectable Needle - Product Description
    • Becton Dickinson and Co Company Overview
      • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table BD Evolve On-body Injector - Product Status
        • Table BD Evolve On-body Injector - Product Description
        • Table BD Libertas Wearable Injector - Product Status
        • Table BD Libertas Wearable Injector - Product Description
        • Table BD Neopak Xtraflow - Product Status
        • Table BD Neopak Xtraflow - Product Description
    • Bespak Europe Ltd Company Overview
      • Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table INJ200 Autoinjector - Product Status
        • Table INJ200 Autoinjector - Product Description
        • Table Lila Mix Injector - Product Status
        • Table Lila Mix Injector - Product Description
    • Biocorp Production SA Company Overview
      • Biocorp Production SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocorp Production SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injay - Product Status
        • Table Injay - Product Description
    • BioCorRx Inc Company Overview
      • BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Naltrexone Implant - BICX101 - Product Status
        • Table Injectable Naltrexone Implant - BICX101 - Product Description
        • Table Naltrexone Implant - BICX102 - Product Status
        • Table Naltrexone Implant - BICX102 - Product Description
        • Table Naltrexone Implant - BICX104 - Product Status
        • Table Naltrexone Implant - BICX104 - Product Description
        • Table BioCorRx Inc - Ongoing Clinical Trials Overview
        • Table Naltrexone Implant - BICX102 - Evaluate the Effectiveness of BioCorRx Recovery Program for Alcohol and/or Opioid Use Disorders
    • Biorchestra Co Ltd Company Overview
      • Biorchestra Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biorchestra Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table RNA Drug Delivery System - Product Status
        • Table RNA Drug Delivery System - Product Description
    • BioRestorative Therapies Inc Company Overview
      • BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BRTX-100 - Product Status
        • Table BRTX-100 - Product Description
        • Table Curved Needle Device - Product Status
        • Table Curved Needle Device - Product Description
        • Table BioRestorative Therapies Inc - Ongoing Clinical Trials Overview
        • Table BRTX-100 - A Phase II, Double-blind, Saline-controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX 100 for Patients with Chronic Lumbar Disc Disease (cLDD)
    • Bioxis Pharmaceuticals Company Overview
      • Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vaccine Delivery Device - Product Status
        • Table Vaccine Delivery Device - Product Description
    • BoneSupport AB Company Overview
      • BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerament|G - Product Status
        • Table Cerament|G - Product Description
        • Table BoneSupport AB - Ongoing Clinical Trials Overview
        • Table Cerament|G - CERAMENT G Device Registry
        • Table Cerament|G - Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network - CONVICTION Study
        • Table Cerament|G - Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis
    • Brigham and Women's Hospital Company Overview
      • Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table i2T2 Device - Product Status
        • Table i2T2 Device - Product Description
    • Brixton Biosciences Inc Company Overview
      • Brixton Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Brixton Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coolio Therapy - Product Status
        • Table Coolio Therapy - Product Description
    • Burke Pharmaceuticals LLC Company Overview
      • Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BURKE201 Needle Injection Pen - Product Status
        • Table BURKE201 Needle Injection Pen - Product Description
    • Calla Health Foundation Company Overview
      • Calla Health Foundation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Calla Health Foundation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automated Needle Injector - Product Status
        • Table Automated Needle Injector - Product Description
    • Cambridge Consultants Ltd Company Overview
      • Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flexi-ject - Product Status
        • Table Flexi-ject - Product Description
    • Camurus AB Company Overview
      • Camurus AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Camurus AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table CAM2029 Pre-Filled Syringe - Product Status
        • Table CAM2029 Pre-Filled Syringe - Product Description
        • Table CAM2032 Pre-Filled Syringe - Product Status
        • Table CAM2032 Pre-Filled Syringe - Product Description
        • Table CAM2038 Depot Injection - Product Status
        • Table CAM2038 Depot Injection - Product Description
        • Table CAM2043 Pre-Filled Injection - Product Status
        • Table CAM2043 Pre-Filled Injection - Product Description
        • Table CAM2047 Pre-Filled Syringe - Product Status
        • Table CAM2047 Pre-Filled Syringe - Product Description
    • Carmot Therapeutics Inc Company Overview
      • Carmot Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carmot Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CT-868 Pen Injector - Product Status
        • Table CT-868 Pen Injector - Product Description
        • Table Carmot Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table CT-868 Pen Injector - A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Participants with Type 1 Diabetes Mellitus
    • Case Western Reserve University Company Overview
      • Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pressure Driven Local Drug Delivery System - Liver Cancer - Product Status
        • Table Pressure Driven Local Drug Delivery System - Liver Cancer - Product Description
    • Cincinnati Children's Hospital Medical Center Company Overview
      • Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pre-Filled Syringe With Flush - Product Status
        • Table Pre-Filled Syringe With Flush - Product Description
    • Clearside BioMedical Inc Company Overview
      • Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SCS Microinjector - Product Status
        • Table SCS Microinjector - Product Description
        • Table Clearside BioMedical Inc - Ongoing Clinical Trials Overview
        • Table SCS Microinjector - A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects with Primary Indeterminate Lesions and Small Choroidal Melanoma
        • Table SCS Microinjector - A Phase 2, Randomized, Dose-escalation, Observation-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered via a Single Suprachoroidal Space (SCS) Injections in Participants With Diabetic Retinopathy (DR) Without Center Involved-diabetic Macular Edema (CI-DME): ALTITUDE
        • Table SCS Microinjector - A Phase 2, Randomized, Dose-escalation, Ranibizumab-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered Via One or Two Suprachoroidal Space (SCS) Injections in Participants with Neovascular Age-Related Macular Degeneration (nAMD): AAVIATE
        • Table SCS Microinjector - A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
        • Table SCS Microinjector - ODYSSEY: A Phase 2b Study of Suprachoroidally Administered CLS-AX in Participants With Neovascular Age-Related Macular Degeneration
    • Coherus BioSciences Inc Company Overview
      • Coherus BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coherus BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table UDENYCA AI - Product Status
        • Table UDENYCA AI - Product Description
        • Table UDENYCA OBI - Product Status
        • Table UDENYCA OBI - Product Description
    • Copernicus Sp zoo Company Overview
      • Copernicus Sp zoo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Copernicus Sp zoo Pipeline Products & Ongoing Clinical Trials Overview
        • Table PENDURA EVO - Product Status
        • Table PENDURA EVO - Product Description
    • CrossCoat Medical LLC Company Overview
      • CrossCoat Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CrossCoat Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CCM-D - Product Status
        • Table CCM-D - Product Description
    • Crossject SA Company Overview
      • Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZENEO Hydrocortisone Autoinjector - Product Status
        • Table ZENEO Hydrocortisone Autoinjector - Product Description
    • CSL Behring LLC Company Overview
      • CSL Behring LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CSL Behring LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hizentra 50mL Prefilled Syringe - Product Status
        • Table Hizentra 50mL Prefilled Syringe - Product Description
    • Curer Inc Company Overview
      • Curer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Curer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Whitlockite-Based Cement - Product Status
        • Table Injectable Whitlockite-Based Cement - Product Description
    • DALI Medical Devices Ltd. Company Overview
      • DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAN-DV - Product Status
        • Table SAN-DV - Product Description
        • Table SAN-DV Pro - Product Status
        • Table SAN-DV Pro - Product Description
        • Table SAN-In - Product Status
        • Table SAN-In - Product Description
        • Table SAN-L - Product Status
        • Table SAN-L - Product Description
        • Table SAN-P - Product Status
        • Table SAN-P - Product Description
        • Table Synnect - Product Status
        • Table Synnect - Product Description
    • DelSite, Inc. (Inactive) Company Overview
      • DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GelSure - Product Status
        • Table GelSure - Product Description Application Vaccine Delivery
    • DelSiTech Ltd Company Overview
      • DelSiTech Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DelSiTech Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DST1308 - Product Status
        • Table DST1308 - Product Description
        • Table Injectable Depot - HIV Prevention - Product Status
        • Table Injectable Depot - HIV Prevention - Product Description
        • Table Injectable Depot - Pregnancy Prevention - Product Status
        • Table Injectable Depot - Pregnancy Prevention - Product Description
        • Table Long-Acting Controlled Release Therapy Device - Ophthalmology - Product Status
        • Table Long-Acting Controlled Release Therapy Device - Ophthalmology - Product Description
    • Department of Biomedical Engineering Columbia University Company Overview
      • Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table AquaDrive - Product Status
        • Table AquaDrive - Product Description
    • Difinity Solutions Company Overview
      • Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview
        • Table Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeedSafe - Product Status
        • Table NeedSafe - Product Description
    • Drexel University Company Overview
      • Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Hydrogel - Product Status
        • Table Injectable Hydrogel - Product Description
    • Duoject Medical Systems Inc Company Overview
      • Duoject Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duoject Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Maverick-Emergency Auto-Injector - Product Status
        • Table Maverick-Emergency Auto-Injector - Product Description
    • E3D Elcam Drug Delivery Devices Company Overview
      • E3D Elcam Drug Delivery Devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table E3D Elcam Drug Delivery Devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flexi-Q eMU-C - Product Status Market Category Drug Delivery Devices-->Injectable Drug Delivery
        • Table Flexi-Q eMU-C - Product Description
        • Table Flexi-Q PFS - Product Status
        • Table Flexi-Q PFS - Product Description Application Injectable Drug Delivery
        • Table Patch Pump (eLVD) - Product Status
        • Table Patch Pump (eLVD) - Product Description
    • Ebenroth BV Company Overview
      • Ebenroth BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ebenroth BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table EpiWatch 1.0 - Product Status
        • Table EpiWatch 1.0 - Product Description
        • Table EpiWatch 2.0 - Product Status
        • Table EpiWatch 2.0 - Product Description
    • Ecole Polytechnique Federale de Lausanne Company Overview
      • Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPOT-RVC - Product Status
        • Table SPOT-RVC - Product Description
    • EmboMedics Inc Company Overview
      • EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Second Generation Injectable Microsphere - Product Status
        • Table Second Generation Injectable Microsphere - Product Description
    • Embryyo Technologies Pvt Ltd Company Overview
      • Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auto-injector - Product Status
        • Table Auto-injector - Product Description
    • Emergent BioSolutions Inc Company Overview
      • Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AP007 - Sustained Release Nalmefene Injectable Device - Product Status
        • Table AP007 - Sustained Release Nalmefene Injectable Device - Product Description
        • Table D4 Auto Injector - Product Status
        • Table D4 Auto Injector - Product Description
        • Table EGRD-001 - Product Status
        • Table EGRD-001 - Product Description
        • Table Emergard - Product Status
        • Table Emergard - Product Description
        • Table Trobigard - Product Status
        • Table Trobigard - Product Description
    • EP Global Communications Inc (Inactive) Company Overview
      • EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table MEMS Trigger Point Needle Device - Product Status
        • Table MEMS Trigger Point Needle Device - Product Description
    • EpicentRx Inc Company Overview
      • EpicentRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EpicentRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table eLoop Administration Device - Product Status
        • Table eLoop Administration Device - Product Description
        • Table EpicentRx Inc - Ongoing Clinical Trials Overview
        • Table Randomized Study of RRx-001 Administered Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer
    • Establishment Labs SA Company Overview
      • Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Motiva Injector - Product Status
        • Table Motiva Injector - Product Description
    • Eveon SAS Company Overview
      • Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automated Injection Device - Product Status
        • Table Automated Injection Device - Product Description
        • Table Injection System - Product Status
        • Table Injection System - Product Description
    • EyeCool Therapeutics Inc Company Overview
      • EyeCool Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeCool Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ETX-4143 - Product Status
        • Table ETX-4143 - Product Description
        • Table EyeCool Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table ETX-4143 - A First In Human Safety Study Of Etx-4143 (A Topical Cooling Device For The Eye) In Subjects With Chronic Eye Pain
    • EyePoint Pharmaceuticals Inc Company Overview
      • EyePoint Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyePoint Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Durasert - Front Of Eye Disease - Product Status
        • Table Durasert - Front Of Eye Disease - Product Description
        • Table Durasert - Knee Osteoarthritis - Product Status
        • Table Durasert - Knee Osteoarthritis - Product Description
        • Table Durasert - Latanoprost Implant - Product Status
        • Table Durasert - Latanoprost Implant - Product Description
        • Table EYP-1901 - Anti-VEGF Bioerodible Durasert - Product Status
        • Table EYP-1901 - Anti-VEGF Bioerodible Durasert - Product Description
        • Table Tethadur System - Product Status
        • Table Tethadur System - Product Description
        • Table YUTIQ 50 - Product Status
        • Table YUTIQ 50 - Product Description
        • Table EyePoint Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table EYP-1901 - Anti-VEGF Bioerodible Durasert - A Phase 2, Multicenter, Prospective, Double-masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Sham for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
        • Table EYP-1901 - Anti-VEGF Bioerodible Durasert - A Phase 2, Multicenter, Prospective, Randomized, Double-Masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects with Wet AMD
    • F. Hoffmann-La Roche Ltd Company Overview
      • F. Hoffmann-La Roche Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table F. Hoffmann-La Roche Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Susvimo Port Delivery System (PDS) - Product Status
        • Table Susvimo Port Delivery System (PDS) - Product Description
        • Table F. Hoffmann-La Roche Ltd - Ongoing Clinical Trials Overview
        • Table Susvimo Port Delivery System (PDS) - A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-related Macular Degeneration (Portal)
        • Table Susvimo Port Delivery System (PDS) - A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active Comparator Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Chinese Patients With Neovascular Age-Related Macular Degeneration
        • Table Susvimo Port Delivery System (PDS) - A Phase IIIb/IV, Multicenter, Open-label, Single-arm Study of the Efficacy and Safety of the Port Delivery System with Ranibizumab In Patients with Neovascular Age-related Macular Degeneration Previously Treated with Intravitreal Agents Other than Ranibizumab
    • FHC Inc Company Overview
      • FHC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FHC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intracerebral Microinjection Instrument - Product Status
        • Table Intracerebral Microinjection Instrument - Product Description
    • FluGen Inc Company Overview
      • FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flugen 101.2 Microneedle-Based Delivery Device - Product Status
        • Table Flugen 101.2 Microneedle-Based Delivery Device - Product Description
        • Table Microneedle Based Delivery Device - Human Papillomavirus - Product Status
        • Table Microneedle Based Delivery Device - Human Papillomavirus - Product Description
        • Table Microneedle Delivery Device - Pneumococal - Product Status
        • Table Microneedle Delivery Device - Pneumococal - Product Description
        • Table Microneedle Delivery Device - Seasonal TIV - Product Status
        • Table Microneedle Delivery Device - Seasonal TIV - Product Description
        • Table Multivaccine Delivering Microneedle Based Device - Product Status
        • Table Multivaccine Delivering Microneedle Based Device - Product Description
    • Fresenius Kabi AG Company Overview
      • Fresenius Kabi AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fresenius Kabi AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pegfilgrastim - Pre-Filled Syringe - Product Status
        • Table Pegfilgrastim - Pre-Filled Syringe - Product Description
    • GeneSYS-ID Inc Company Overview
      • GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rx MyDOSE - Product Status
        • Table Rx MyDOSE - Product Description
    • Georgia Institute of Technology Company Overview
      • Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table ePatch - Product Status
        • Table ePatch - Product Description
        • Table Injection Device - Eye Disease - Product Status
        • Table Injection Device - Eye Disease - Product Description
        • Table Georgia Institute of Technology - Ongoing Clinical Trials Overview
        • Table ePatch - Develop and Validate Machine-Learning Algorithm to Detect Atrial Fibrillation with Wearable Devices
        • Table ePatch - ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation
    • Ghent University Company Overview
      • Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Poly-Electrolyte Micropartcle (PEM) System - Product Status
        • Table Poly-Electrolyte Micropartcle (PEM) System - Product Description
    • Globe Medical Tech Inc (Inactive) Company Overview
      • Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual Chamber Safety Prefillable Syringe - Product Status
        • Table Dual Chamber Safety Prefillable Syringe - Product Description
        • Table Single Chamber Safety Prefillable Syringe - Product Status
        • Table Single Chamber Safety Prefillable Syringe - Product Description
    • Halozyme Therapeutics Inc Company Overview
      • Halozyme Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Halozyme Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ENHANZE Plus Auto-Injector - Product Status
        • Table ENHANZE Plus Auto-Injector - Product Description
    • Hillmed Inc Company Overview
      • Hillmed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hillmed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PelviMap System - Product Status
        • Table PelviMap System - Product Description
        • Table Hillmed Inc - Ongoing Clinical Trials Overview
        • Table PelviMap System - An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
    • Ichor Medical Systems Inc Company Overview
      • Ichor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ichor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TriGrid ID - Product Status
        • Table TriGrid ID - Product Description
        • Table TriGrid IM - Product Status
        • Table TriGrid IM - Product Description
        • Table Ichor Medical Systems Inc - Ongoing Clinical Trials Overview
        • Table TriGrid IM - A Pilot Study to Assess the Safety and Immunogenicity of a Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
    • Immunovant Inc Company Overview
      • Immunovant Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunovant Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IMVT-1401 - Product Status
        • Table IMVT-1401 - Product Description
    • Impulse Biomedical Company Overview
      • Impulse Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Impulse Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZiBiPen - Product Status
        • Table ZiBiPen - Product Description
    • Inovio Pharmaceuticals Inc Company Overview
      • Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Jupiter Jet - Product Status
        • Table Jupiter Jet - Product Description
    • InVivo Therapeutics Corp Company Overview
      • InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table TrailMaker - Product Status
        • Table TrailMaker - Product Description
    • iScience Interventional Inc Company Overview
      • iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iScience Smart Needle - Product Status
        • Table iScience Smart Needle - Product Description
    • JCR Pharmaceuticals Co Ltd Company Overview
      • JCR Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table JCR Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Growject - SHOX Deficiency - Product Status
        • Table Growject - SHOX Deficiency - Product Description
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table MPACT-Needle - Product Status
        • Table MPACT-Needle - Product Description
    • LG Chem Ltd Company Overview
      • LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Y-Phasic - Product Status
        • Table Y-Phasic - Product Description
    • Liposphere Ltd Company Overview
      • Liposphere Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liposphere Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table AqueousJoint - Product Status
        • Table AqueousJoint - Product Description
        • Table Liposphere Ltd - Ongoing Clinical Trials Overview
        • Table AqueousJoint - Efficacy and Safety of AqueousJoint Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: Prospective, Placebo Controlled, Randomized, Double-Blinded Study
    • Love Lifesciences LLC Company Overview
      • Love Lifesciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Love Lifesciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table UniPen - Product Status
        • Table UniPen - Product Description
    • LyoGo Company Overview
      • LyoGo Pipeline Products & Ongoing Clinical Trials Overview
        • Table LyoGo Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuickStick - Product Status
        • Table QuickStick - Product Description
    • Mallinckrodt Plc Company Overview
      • Mallinckrodt Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mallinckrodt Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Device - Autoimmune Disorders - Product Status
        • Table Drug Delivery Device - Autoimmune Disorders - Product Description
    • Medovate Ltd Company Overview
      • Medovate Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medovate Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Safira (SAFer Injection system for Regional Anaesthesia) - Product Status
        • Table Safira (SAFer Injection system for Regional Anaesthesia) - Product Description
        • Table Safira NRFit Syringe - Product Status
        • Table Safira NRFit Syringe - Product Description
        • Table Safira Palm Operator - Product Status
        • Table Safira Palm Operator - Product Description
        • Table Safira Foot Pedal - Product Status
        • Table Safira Foot Pedal - Product Description
    • Mercator MedSystems Inc Company Overview
      • Mercator MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mercator MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bullfrog Micro-Infusion Device - Below The Knee - Product Status
        • Table Bullfrog Micro-Infusion Device - Below The Knee - Product Description
        • Table Bullfrog Micro-Infusion Device - Deep Vein Thrombosis - Product Status
        • Table Bullfrog Micro-Infusion Device - Deep Vein Thrombosis - Product Description
        • Table Mercator MedSystems Inc - Ongoing Clinical Trials Overview
        • Table Bullfrog Micro-Infusion Device - Below The Knee - Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes below the Knee: TANGO
        • Table Bullfrog Micro-Infusion Device - Below The Knee - Temsirolimus Alone or Paired with Dexamethasone Delivered to the Adventitia to Enhance Clinical Efficacy after Femoropopliteal Revascularization
        • Table Bullfrog Micro-Infusion Device - Deep Vein Thrombosis - Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation after Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT (DEXTERITY-SCI)
    • Mertiva AB Company Overview
      • Mertiva AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mertiva AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nerve Targeting Drug Delivery System - Product Status
        • Table Nerve Targeting Drug Delivery System - Product Description
    • Milestone Scientific Inc Company Overview
      • Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompuFlo System - Cosmetic Surgery - Product Status
        • Table CompuFlo System - Cosmetic Surgery - Product Description
        • Table CompuFlo System - General Medical Injection - Product Status
        • Table CompuFlo System - General Medical Injection - Product Description
        • Table CompuFlo System - Ophthalmic Injection - Product Status
        • Table CompuFlo System - Ophthalmic Injection - Product Description
        • Table CompuFlo System - Peripheral Nerve Block - Product Status
        • Table CompuFlo System - Peripheral Nerve Block - Product Description
        • Table CompuFlo System - Self-Administered Drug Delivery - Product Status
        • Table CompuFlo System - Self-Administered Drug Delivery - Product Description
        • Table CompuFlo System - Thoracic - Product Status
        • Table CompuFlo System - Thoracic - Product Description
    • Mingche Biotechnology (Suzhou) Co Ltd Company Overview
      • Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Drug Delivery Device - Product Status
        • Table Microneedle Drug Delivery Device - Product Description
    • Monash University Company Overview
      • Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hydrogel-Based Delivery Device - Product Status
        • Table Hydrogel-Based Delivery Device - Product Description
    • Morimoto Pharma Co Ltd Company Overview
      • Morimoto Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Morimoto Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table S.A.F.E. Syringe Kit - Product Status
        • Table S.A.F.E. Syringe Kit - Product Description
    • NanoSyrinx Ltd Company Overview
      • NanoSyrinx Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoSyrinx Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanosyringe - Product Status
        • Table Nanosyringe - Product Description
    • Nemera La Verpilliere Company Overview
      • Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Wearable Device - Product Status
        • Table Smart Wearable Device - Product Description
        • Table Symbioze - Product Status
        • Table Symbioze - Product Description
    • Nipro Corp Company Overview
      • Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injection Kit - Product Status
        • Table Injection Kit - Product Description
    • Nordic Group BV Company Overview
      • Nordic Group BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nordic Group BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nordimet Auto-Injector - Product Status
        • Table Nordimet Auto-Injector - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Ultrasound-Based Blood-Brain-Barrier Device - Product Status
        • Table Implantable Ultrasound-Based Blood-Brain-Barrier Device - Product Description
    • Nota Laboratories LLC Company Overview
      • Nota Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nota Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Catheter Lock Solution - Product Status
        • Table Catheter Lock Solution - Product Description
    • NovaXS Biotech Corp. Company Overview
      • NovaXS Biotech Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NovaXS Biotech Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Telosis - Product Status
        • Table Telosis - Product Description
    • Novo Nordisk AS Company Overview
      • Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Concizumab Pen Injector - Product Status
        • Table Concizumab Pen Injector - Product Description
        • Table Novo Nordisk AS - Ongoing Clinical Trials Overview
        • Table Concizumab Pen Injector - Efficacy and Safety of Concizumab Prophylaxis in Patients with Haemophilia A or B with Inhibitors
        • Table Concizumab Pen Injector - Efficacy and Safety of Concizumab Prophylaxis in Patients with Haemophilia a or B without Inhibitors
    • Novosanis NV Company Overview
      • Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAX-ID - Product Status
        • Table VAX-ID - Product Description
    • NuvOx Pharma LLC Company Overview
      • NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syringe Sonication Device - Product Status
        • Table Syringe Sonication Device - Product Description
    • Ocular Therapeutix Inc Company Overview
      • Ocular Therapeutix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ocular Therapeutix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OTX-TKI - Product Status
        • Table OTX-TKI - Product Description
        • Table Ocular Therapeutix Inc - Ongoing Clinical Trials Overview
        • Table OTX-TKI - A Phase 1 Open-label, Dose Escalation Study of OTX-TKI for Intravitreal Use in Subjects with Neovascular Agerelated Macular Degeneration (AMD)
        • Table OTX-TKI - A Prospective Multicenter, Double-masked, Randomized, Parallel-group, Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI (Axitinib Implant) for Intravitreal Use in Subjects with Neovascular Age-related Macular Degeneration (nAMD)
    • Ohio State University Company Overview
      • Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Drug Delivery System - Product Status
        • Table Smart Drug Delivery System - Product Description
    • Old Dominion University Company Overview
      • Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermal Gene Electro Transfer Device - Product Status
        • Table Thermal Gene Electro Transfer Device - Product Description
    • Osteo Pharma BV Company Overview
      • Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table OsteoActivator M - Product Status
        • Table OsteoActivator M - Product Description
    • Oval Medical Technologies Ltd Company Overview
      • Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EpiQ - Product Status
        • Table EpiQ - Product Description
        • Table Sumalen Ovali - Product Status
        • Table Sumalen Ovali - Product Description
    • Owen Mumford Ltd Company Overview
      • Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table UniSafe Auto-injector - Product Status
        • Table UniSafe Auto-injector - Product Description
        • Table UniSafe Connected Auto-injector - Product Status
        • Table UniSafe Connected Auto-injector - Product Description
    • Palatin Technologies Inc Company Overview
      • Palatin Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Palatin Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vyleesi - Product Status
        • Table Vyleesi - Product Description
    • Palette Life Sciences AB Company Overview
      • Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Barrigel - Product Status
        • Table Barrigel - Product Description
        • Table Palette Life Sciences AB - Ongoing Clinical Trials Overview
        • Table Barrigel - Contouring Conformance Comparing Barrigel with Surgical Clips for Post-Lumpectomy Cavity Delineation in Breast Cancer
    • Particle Therapeutics Ltd Company Overview
      • Particle Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Particle Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PRT Glucagon Device - Product Status
        • Table PRT Glucagon Device - Product Description
    • Pennsylvania State University Company Overview
      • Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluid Delivery Device - Product Status
        • Table Fluid Delivery Device - Product Description
    • Pfizer Inc Company Overview
      • Pfizer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pfizer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sayana Press - Automated Filling Line - Product Status
        • Table Sayana Press - Automated Filling Line - Product Description
    • Pharmosa Biopharm Inc Company Overview
      • Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table L220 Injection Depot - Product Status
        • Table L220 Injection Depot - Product Description
    • Portal Instruments Inc Company Overview
      • Portal Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portal Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PRIME - Product Status
        • Table PRIME - Product Description
    • Prohibix LLC Company Overview
      • Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epicargo - Product Status
        • Table Epicargo - Product Description
    • Purdue Pharma LP Company Overview
      • Purdue Pharma LP Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue Pharma LP Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nalmefene Prefilled Syringe - Product Status
        • Table Nalmefene Prefilled Syringe - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table EpicPen - Product Status
        • Table EpicPen - Product Description
    • Pykus Therapeutics Inc Company Overview
      • Pykus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pykus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PYK-1105 - Product Status
        • Table PYK-1105 - Product Description
    • QuiO Technologies LLC Company Overview
      • QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Si One - Product Status
        • Table Si One - Product Description
        • Table Si Pen - Product Status
        • Table Si Pen - Product Description
    • Rebel Medicine Corp Company Overview
      • Rebel Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rebel Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alevatrix - Product Status
        • Table Alevatrix - Product Description
    • Recon Therapeutics, LLC Company Overview
      • Recon Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Recon Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LyoKit System - Product Status
        • Table LyoKit System - Product Description
    • Regeneron Pharmaceuticals Inc Company Overview
      • Regeneron Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regeneron Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DUPIXENT Pre-filled Syringe - Product Status
        • Table DUPIXENT Pre-filled Syringe - Product Description
        • Table DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Status
        • Table DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Description
        • Table Injectable Drug Delivery Device - Product Status
        • Table Injectable Drug Delivery Device - Product Description
        • Table Regeneron Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table DUPIXENT Pre-filled Syringe - Interleukin-4Ralpha Blockade by Dupilumab Decreases Staphylococcus Aureus Colonization and Increases Microbial Diversity in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
        • Table DUPIXENT Pre-filled Syringe - The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction
    • Renovos Biologics Ltd Company Overview
      • Renovos Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renovos Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renovite - Product Status
        • Table Renovite - Product Description
    • RepliCel Life Sciences Inc Company Overview
      • RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DermaPrecise Injector - Product Status
        • Table DermaPrecise Injector - Product Description
    • Rescitech Vision Pvt Ltd Company Overview
      • Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Safe Injection System - Product Status
        • Table Safe Injection System - Product Description
    • RetinaPharma Technologies Inc Company Overview
      • RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PhotoTarget Drug Delivery System - Product Status
        • Table PhotoTarget Drug Delivery System - Product Description
    • Re-Vana Therapeutics Ltd Company Overview
      • Re-Vana Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Re-Vana Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeLief Implant - Product Status
        • Table EyeLief Implant - Product Description
        • Table EyeLief-SD - Product Status
        • Table EyeLief-SD - Product Description
        • Table OcuLief Implant - Product Status
        • Table OcuLief Implant - Product Description
    • Roche Pharma AG Company Overview
      • Roche Pharma AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Pharma AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prefilled Syringe - Product Status
        • Table Prefilled Syringe - Product Description
    • SafePush LLC Company Overview
      • SafePush LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SafePush LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SafePush - Product Status
        • Table SafePush - Product Description
    • Sapporo Medical University School of Medicine Company Overview
      • Sapporo Medical University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sapporo Medical University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liposomal Drug Delivery System - Product Status
        • Table Liposomal Drug Delivery System - Product Description
    • Schott AG Company Overview
      • Schott AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Schott AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrated Needle Safety System - Product Status
        • Table Integrated Needle Safety System - Product Description
    • Shanghai Weimu Medical Technology Co Ltd Company Overview
      • Shanghai Weimu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai Weimu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polyvinyl Alcohol Embolization Microsphere - Product Status
        • Table Polyvinyl Alcohol Embolization Microsphere - Product Description
    • SHL Medical USA LLC Company Overview
      • SHL Medical USA LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SHL Medical USA LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sonelokimab Molly Autoinjector - Product Status
        • Table Sonelokimab Molly Autoinjector - Product Description
    • Singapore Eye Research Institute Company Overview
      • Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liposomal Drug Delivery System - Product Status
        • Table Liposomal Drug Delivery System - Product Description
        • Table SERID - Product Status
        • Table SERID - Product Description
    • Societe Industrielle De Sonceboz SA Company Overview
      • Societe Industrielle De Sonceboz SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Societe Industrielle De Sonceboz SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table LVI-P - Product Status
        • Table LVI-P - Product Description
        • Table LVI-V - Product Status
        • Table LVI-V - Product Description
    • Sorrento Therapeutics Inc Company Overview
      • Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sofusa DoseDisc System - Product Status
        • Table Sofusa DoseDisc System - Product Description
    • Southern Medical University Company Overview
      • Southern Medical University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Southern Medical University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Hydrogel - Product Status
        • Table Injectable Hydrogel - Product Description
    • Southwest Research Institute Company Overview
      • Southwest Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Southwest Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Printed Biodegradable Device - Cancer - Product Status
        • Table 3D Printed Biodegradable Device - Cancer - Product Description
    • Spinal Restoration Inc (Inactive) Company Overview
      • Spinal Restoration Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spinal Restoration Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biostat System - Product Status
        • Table Biostat System - Product Description
    • Stevanato Group SpA Company Overview
      • Stevanato Group SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stevanato Group SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table SG Alina - Product Status
        • Table SG Alina - Product Description
        • Table Vertiva On-Body Delivery System - Product Status
        • Table Vertiva On-Body Delivery System - Product Description
    • Subcuject ApS Company Overview
      • Subcuject ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Subcuject ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osmotic Wearable Bolus Injector - Product Status
        • Table Osmotic Wearable Bolus Injector - Product Description
    • Sunshine Guojian Pharmaceutical Shanghai Co Ltd Company Overview
      • Sunshine Guojian Pharmaceutical Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sunshine Guojian Pharmaceutical Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yisaipu Pre-Filled Syringe - Product Status
        • Table Yisaipu Pre-Filled Syringe - Product Description
    • SURGE Therapeutics Inc Company Overview
      • SURGE Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SURGE Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Biodegradable Hydrogel - Product Status
        • Table Injectable Biodegradable Hydrogel - Product Description
    • Takeda Pharmaceutical Co Ltd Company Overview
      • Takeda Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Takeda Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vedolizumab Auto Injector Pen - Product Status
        • Table Vedolizumab Auto Injector Pen - Product Description
        • Table Vedolizumab Pre-Filled Syringe - Product Status
        • Table Vedolizumab Pre-Filled Syringe - Product Description
    • TCB medical devices Company Overview
      • TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epinephrine Auto-Injector Key - Product Status
        • Table Epinephrine Auto-Injector Key - Product Description
    • Tempest Therapeutics Inc Company Overview
      • Tempest Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tempest Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multi-Dose Pen Device - Product Status
        • Table Multi-Dose Pen Device - Product Description
    • Terumo Corp Company Overview
      • Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Large Volume Injector - Product Status
        • Table Large Volume Injector - Product Description
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Device - Product Status
        • Table Injectable Device - Product Description
    • Teva Pharmaceuticals USA Inc Company Overview
      • Teva Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FEXTENFA - Product Status
        • Table FEXTENFA - Product Description
    • TheraKine Inc (Inactive) Company Overview
      • TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioKine - Product Status
        • Table AngioKine - Product Description
        • Table OptiKine - Product Status
        • Table OptiKine - Product Description
    • Twin Star Medical Inc Company Overview
      • Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Porous Hollow Fiber Catheter - Product Status
        • Table Porous Hollow Fiber Catheter - Product Description
    • Unilife Corporation Company Overview
      • Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table EZMix Genesis - Product Status
        • Table EZMix Genesis - Product Description
        • Table EZMix Prodigy - Product Status
        • Table EZMix Prodigy - Product Description
        • Table Ocu-ject - Product Status
        • Table Ocu-ject - Product Description
        • Table Targeted Organ Drug Delivery Device - Product Status
        • Table Targeted Organ Drug Delivery Device - Product Description
        • Table Unifill Finesse - Product Status
        • Table Unifill Finesse - Product Description
        • Table Unifill Select - Product Status
        • Table Unifill Select - Product Description
        • Table Unilife Auto Injector - Product Status
        • Table Unilife Auto Injector - Product Description
        • Table Unitract 3ml And 5ml With Luer Needle - Product Status
        • Table Unitract 3ml And 5ml With Luer Needle - Product Description
    • University College London Company Overview
      • University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soft Robot - Drug Delivery - Product Status
        • Table Soft Robot - Drug Delivery - Product Description
    • University of Calgary Company Overview
      • University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
        • Table Painless Drug Delivery Device - Product Status
        • Table Painless Drug Delivery Device - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Porous Silicon Contraceptive - Product Status
        • Table Biodegradable Porous Silicon Contraceptive - Product Description
        • Table Spinal Injection Device - Product Status
        • Table Spinal Injection Device - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Cannula System - Product Status
        • Table Drug Delivery Cannula System - Product Description
    • University of Connecticut Health Center Company Overview
      • University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hydrogel - Product Status
        • Table Hydrogel - Product Description
    • University of Delaware Company Overview
      • University of Delaware Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Delaware Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Drug Delivery Device - Product Status
        • Table Injectable Drug Delivery Device - Product Description
    • University of Dundee Company Overview
      • University of Dundee Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Dundee Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multipoint Injector - Product Status
        • Table Multipoint Injector - Product Description
    • University of Florida Company Overview
      • University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomaterial Delivery System - Type 1 Diabetes - Product Status
        • Table Biomaterial Delivery System - Type 1 Diabetes - Product Description
        • Table MEMS Device - Product Status
        • Table MEMS Device - Product Description
    • University of Galway Company Overview
      • University of Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Hydrogel - Product Status
        • Table Injectable Hydrogel - Product Description
    • University of Michigan Company Overview
      • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cryo-Anesthesia Administration Device - Product Status
        • Table Cryo-Anesthesia Administration Device - Product Description
    • University of New Mexico Company Overview
      • University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview
        • Table Naloxone Autoinjector - Product Status
        • Table Naloxone Autoinjector - Product Description
    • University of Saskatchewan Company Overview
      • University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auto-Injector System - Product Status
        • Table Auto-Injector System - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery System - Age-Related Macular Degeneration - Product Status
        • Table Drug Delivery System - Age-Related Macular Degeneration - Product Description
    • University of Texas at Austin Company Overview
      • University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanofabricated Drug Delivery Device - Product Status
        • Table Nanofabricated Drug Delivery Device - Product Description
    • University of Texas at San Antonio Company Overview
      • University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Printed Implant - Product Status
        • Table 3D Printed Implant - Product Description
    • University of Texas Health Science Center at Houston Company Overview
      • University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Antibiotic Microsphere - Product Status
        • Table Implantable Antibiotic Microsphere - Product Description
    • University of Texas Rio Grande Valley Company Overview
      • University of Texas Rio Grande Valley Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Rio Grande Valley Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Functionalized Biodegradable Biomaterial System - Product Status
        • Table Injectable Functionalized Biodegradable Biomaterial System - Product Description
    • University of Utah Company Overview
      • University of Utah Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Utah Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hypodermic Needle System - Product Status
        • Table Hypodermic Needle System - Product Description
    • Vanderbilt University Company Overview
      • Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aliquot Delivery System - Product Status
        • Table Aliquot Delivery System - Product Description
    • West Pharmaceutical Services Inc Company Overview
      • West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Self-Injection Device - Product Status
        • Table Next Generation Self-Injection Device - Product Description
    • Windgap Medical Inc Company Overview
      • Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abiliject - Product Status
        • Table Abiliject - Product Description
        • Table ANDIPEN - Product Status
        • Table ANDIPEN - Product Description
        • Table Glucagon Autoinjector - Product Status
        • Table Glucagon Autoinjector - Product Description
        • Table Sulfanegen Autoinjector - Product Status
        • Table Sulfanegen Autoinjector - Product Description
        • Table WG-2024 Autoinjector - Product Status
        • Table WG-2024 Autoinjector - Product Description
        • Table WG-2025 Autoinjector - Product Status
        • Table WG-2025 Autoinjector - Product Description
        • Table WG-2027 Autoinjector - Product Status
        • Table WG-2027 Autoinjector - Product Description
    • Wuhan Tianshiwei Holdings Co Ltd Company Overview
      • Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soluble Microneedle Device - Product Status
        • Table Soluble Microneedle Device - Product Description
    • Xeris Biopharma Holdings Inc Company Overview
      • Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DiazePen - Product Status
        • Table DiazePen - Product Description
    • Ypsomed Holding AG Company Overview
      • Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table YpsoDose - Product Status
        • Table YpsoDose - Product Description
    • Zealand Pharma AS Company Overview
      • Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glepaglutide Pen Injection - Product Status
        • Table Glepaglutide Pen Injection - Product Description
    • ZebraSci Inc Company Overview
      • ZebraSci Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZebraSci Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Evolve Wearable Injector - Product Status
        • Table Evolve Wearable Injector - Product Description
        • Table Prefilled Syringe For IV Connection - 10mL - Product Status
        • Table Prefilled Syringe For IV Connection - 10mL - Product Description
        • Table Prefilled Syringe For IV Connection - 2.25mL - Product Status
        • Table Prefilled Syringe For IV Connection - 2.25mL - Product Description
    • Zosano Pharma Corp Company Overview
      • Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antiemetic Microneedle Patch - Product Status
        • Table Antiemetic Microneedle Patch - Product Description
        • Table Microneedle Patch - Large Molecules - Product Status
        • Table Microneedle Patch - Large Molecules - Product Description
  • Injectable Drug Delivery- Recent Developments
    • Dec 13, 2023: Pfizer Provides Full-Year 2024 Guidance
    • Dec 04, 2023: Stefan Blomsterberg Appointed as New CEO of CELLINK Bioprinting AB
    • Dec 01, 2023: FDA Roundup: December 1, 2023
    • Nov 30, 2023: Evaluating Plastic Syringes Made in China for Potential Device Failures: FDA Safety Communication
    • Nov 21, 2023: BD Names Dr. Ronald Silverman as Chief Medical Officer
    • Nov 17, 2023: Lilly to Expand Injectable Manufacturing Capacity With Planned $2.5 Billion Site in Germany
    • Nov 16, 2023: Once-Weekly TransCon CNP Achieved Primary Efficacy Objective in AccomplisH China Phase 2 Trial
    • Nov 16, 2023: Halozyme Announces argenx Receives European Commission Approval of VYVGART SC with ENHANZE for Generalized Myasthenia Gravis
    • Nov 15, 2023: Ascendis Pharma Resubmits NDA for TransCon PTH to the U.S. FDA
    • Nov 15, 2023: Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023
    • Nov 14, 2023: Stayble Therapeutics Publishes Interim Report for the Third Quarter of 2023 Tuesday, November 14, 2023
    • Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
    • Nov 13, 2023: Brixton Biosciences' Coolio Therapy Granted Breakthrough Device Designation by the FDA
    • Nov 08, 2023: Dr. Reddy's Laboratories Elevates Pankaj Phatak as Director & Group HR Head
    • Nov 08, 2023: Biogen Reports Third Quarter 2023 Results and Updates Full Year 2023 Guidance
    • Nov 07, 2023: Clearside Biomedical's Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
    • Nov 07, 2023: Clearside Biomedical's Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
    • Nov 07, 2023: Viatris Reports Strong Financial and Operational Results for the Third Quarter 2023 and Reaffirms Full-Year 2023 Adjusted EBITDA and Free Cash Flow Guidance Ranges
    • Nov 07, 2023: Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
    • Nov 06, 2023: Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative ‘GLP-1 Obesity Treatment' With Advanced Microneedle Technology for Sustained Weekly Efficacy
    • Nov 06, 2023: Delcath Systems to Host Third Quarter 2023 Results Call
    • Nov 06, 2023: Halozyme Reports Third Quarter 2023 Financial and Operating Results
    • Nov 01, 2023: Polyactiva Reports Promising Clinical Trial Results for Its 6-Month Sustained Drug Delivery, Biodegradable Ocular Implant in Glaucoma Patients.
    • Oct 28, 2023: Pfizer Q2 Results: Drug Maker's Profit Declines 52% To Rs 149 Crore
    • Oct 27, 2023: Dr. Reddy's Announces Q2 FY24 Financial Results
    • Oct 26, 2023: Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease
    • Oct 19, 2023: Positive Topline Results Reported from Bristol Myers Squibb's Phase 3 CheckMate-67T Trial of Subcutaneous Nivolumab with Halozyme's ENHANZE Drug Delivery Technology for Advanced or Metastatic Clear Cell Renal Cell Carcinoma
    • Oct 19, 2023: DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
    • Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations
    • Oct 16, 2023: Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery
    • Oct 16, 2023: Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting
    • Oct 12, 2023: Biogen Lays Off 113 Reata Employees Months After $7B Acquisition
    • Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Oct 03, 2023: Ocular Therapeutix Announces Initiation of its First Pivotal Clinical Trial of OTX-TKI in Wet AMD
    • Oct 03, 2023: Samuel Kunzli succeeds Niklaus Ramseier as CFO and member of the Executive Board
    • Oct 02, 2023: Apellis Announces U.S. FDA Approval of the EMPAVELI Injector, a Device to Streamline Self-Administration
    • Oct 02, 2023: Ascendis Presents TransCon PTH Data at the American Thyroid Association Annual Meeting
    • Oct 02, 2023: Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
    • Oct 02, 2023: Gerald W. Bruce Appointed President and CEO of Novvae Pharmaceuticals
    • Sep 29, 2023: Samuel Kunzli succeeds Niklaus Ramseier as CFO and member of the Executive Board
    • Sep 29, 2023: Samuel Kunzli Succeeds Niklaus Ramseier as CFO and Member of the Executive Board
    • Sep 28, 2023: OcuJect Obtains 510(k) Clearance for OcuSafe Needle
    • Sep 28, 2023: Teva Announces Changes to Executive Management Team
    • Sep 28, 2023: Pfizer Appoints New Chief IR Officer
    • Sep 25, 2023: FDA Issues Complete Response Letter (CRL) for UDENYCA ONBODY Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections
    • Sep 23, 2023: Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon hGH in Pediatric Growth Hormone Deficiency
    • Sep 20, 2023: Ypsomed Concludes a Long-Term Supply Agreement for Large Quantities of Autoinjectors
    • Sep 19, 2023: Dr. Reddy's Laboratories Appoints Dr. Alpna Hansraj Seth as Additional Director
    • Sep 19, 2023: Catalent Appoints David McErlane as Biologics Segment Leader
    • Sep 14, 2023: Ian Fuller Named Vice President of Operations at Jubilant HollisterStier Contract Manufacturing
    • Sep 12, 2023: Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
    • Sep 06, 2023: Biogen Appoints Jane Grogan as Head of Research
    • Aug 31, 2023: Sanofi Appoints a Venture Investor to R&D Head as Executive Team Expands
    • Aug 29, 2023: Halozyme Announces Approval of Roche's Tecentriq Subcutaneous (SC) with ENHANZE in Great Britain
    • Aug 29, 2023: Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 23, 2023: BD to Present at Investor Healthcare Conferences
    • Aug 23, 2023: Vaxxas Awarded US$3.67 Million (Au$5.4 Million) From Global Charitable Foundation, Wellcome, For Human Clinical Study Of Typhoid Vaccination Using Needle-free Vaccine Patch
    • Aug 22, 2023: Stayble Therapeutics Publishes Half-Year Report for 2023 Tue, Aug 22, 2023
    • Aug 16, 2023: Emergent BioSolutions Announces Demise of Jerome Hauer, Ph.D., Director
    • Aug 15, 2023: Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023
    • Aug 08, 2023: Phani Mitra appointed as Chief Digital and Information Officer at Dr. Reddy's
    • Aug 08, 2023: Halozyme Reports Second Quarter 2023 Financial and Operating Results
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Aug 07, 2023: Palatin Announces Direct-To-Consumer Telehealth Partnership With Upscripthealth for Vyleesi
    • Aug 07, 2023: Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges
    • Aug 07, 2023: Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges
    • Aug 03, 2023: Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income Countries
    • Aug 03, 2023: Medovate Receives Innovative Technology Contract From Vizient for Safira (Safer Injection for Regional Anesthesia)
    • Aug 03, 2023: Delcath Systems to File its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following Week
    • Aug 03, 2023: Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
    • Aug 02, 2023: EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
    • Aug 01, 2023: Becton Dickinson Receives Additional 510(k) Clearance for 0.9% Sodium Chloride Injection, USP, BD PosiFlush SP Syringe
    • Jul 31, 2023: Clearside Biomedical Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Duration of Effect in Data Presentation at the American Society of Retina Specialists 41st Annual Scientific Meeting
    • Jul 26, 2023: N4 Pharma Announces Patent Grant
    • Jul 26, 2023: Dr. Reddy's Laboratories Announces Unaudited Financial Results for the quarter ended June 30, 2023
    • Jul 26, 2023: Dr. Reddy's Laboratories Announces Retirement of Independent Director of the Company
    • Jul 26, 2023: Dr. Reddy's Laboratories Announces Change in Senior Management
    • Jul 25, 2023: CELLINK and AXT Join Forces to Expand Access to Innovative Bioprinting Technologies in Oceania
    • Jul 18, 2023: BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
    • Jul 13, 2023: SiSaf Announces Appoints Nikos Tzagkarakis as Chief A.I. Officer
    • Jul 11, 2023: Fresenius Kabi Introduces New Presentation for Fentanyl Citrate Injection, USP in Simplist Ready-to-Administer Prefilled Syringes
    • Jul 10, 2023: EyePoint Pharmaceuticals Announces Appointment of Jay S. Duke as Chief Executive Officer Transition
    • Jul 07, 2023: BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
    • Jul 05, 2023: Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2
    • Jun 27, 2023: BioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any Changes
    • Jun 27, 2023: Emergent BioSolutions Announces CEO Transition
    • Jun 20, 2023: Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer
    • Jun 18, 2023: Vaxxas Opens World-Class Manufacturing Facility to Produce Proprietary Needle-Free Vaccine Patch for Late-Stage Clinical Trials and First Commercial Products
    • Jun 12, 2023: Stevanato Group Presents Vertiva, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (Up to 10ML)
    • Jun 07, 2023: Delcath Systems Announces Sandra Pennell as Senior Vice President of Finance
    • Jun 05, 2023: EyePoint Pharmaceuticals Completes Enrollment in Phase 2 PAVIA Clinical Trial of EYP-1901 in Non-Proliferative Diabetic Retinopathy
    • May 30, 2023: Palette Life Sciences welcomes New Barrigel Center of Excellence program designations
    • May 30, 2023: Establishment labs announces CE mark approval for minimally invasive surgical tools
    • May 27, 2023: Raymed Labs announces audited standalone financial results for quarter and year ended march 31, 2023
    • May 22, 2023: US FDA Approves the Cyltezo Pen, a New Autoinjector Option, Ahead of July 1 Commercial Launch
    • May 15, 2023: Tetris Pharma launches Ogluo in Denmark And Norway
    • May 15, 2023: Adamis Pharmaceuticals reports Q1 2023 financial results and provides corporate update
    • May 12, 2023: Delcath Systems provides business update and reports preliminary first quarter 2023 financial results
    • May 11, 2023: Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023
    • May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • May 11, 2023: Gwangju Institute of Science and Technology Researchers develop injectable bioelectrodes with tunable lifetimes
    • May 10, 2023: Dr. Reddy's Q4 & FY23 Financial Results
    • May 09, 2023: Patients asked to return Emerade 300 and 500 microgram adrenaline pens for replacement
    • May 09, 2023: Emergent BioSolutions reports financial results for first quarter 2023
    • May 08, 2023: Adamis Pharmaceuticals schedules Q1 2023 financial results conference call and corporate update
    • May 05, 2023: Milestone Scientific schedules first quarter 2023 financial results and business update conference call
    • May 03, 2023: Raymed Labs Appoints Ms. Shreya Dave as Company Secretary and Compliance Officer
    • May 03, 2023: Delcath Systems to host first quarter 2023 results
    • May 03, 2023: CELLINK Unveils Third Generation LUMEN X - The New Standard for DLP Bioprinting
    • Apr 29, 2023: Raymed Labs announces resignation of company secretary and compliance officer, Ms. Priyanka Sisodia
    • Apr 19, 2023: Emergent BioSolutions to release first quarter 2023 financial results and conduct conference call on May 9, 2023
    • Apr 18, 2023: Owen Mumford Wins Distinction in Red Dot Award (Product Design 2023) for Aidaptus Auto-Injector
    • Apr 18, 2023: CSL Behring receives FDA approval for Hizentra (immune globulin subcutaneous [human] 20% liquid) 50mL prefilled syringe
    • Apr 18, 2023: West Korea announces ready pack containment solution extension at COPHEX 2023
    • Apr 12, 2023: Medtronic has a layoff in California
    • Apr 05, 2023: SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
    • Apr 05, 2023: Dymax reveals MD 1045-M multipurpose adhesive for prefilled syringes and injection devices
    • Apr 04, 2023: Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer
    • Apr 03, 2023: Ascendis Pharma provides update on regulatory reviews of TransCon PTH in hypoparathyroidism
    • Apr 03, 2023: Alimera announces expansion of agreement with distribution partner Horus Pharma to include marketing ILUVIEN in the Nordic Countries
    • Mar 27, 2023: Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
    • Mar 20, 2023: Fusion Pharmaceuticals announces first patient dosed in phase 1 study of FPI-2059, a targeted alpha therapy (TAT) for the treatment of solid tumors expressing NTSR1
    • Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • Mar 14, 2023: Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
    • Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
    • Mar 07, 2023: BioCorRx announced interim positive safety and pharmacokinetic results of phase 1 clinical trial at 4th Annual NIH HEAL Initiative Investigator Meeting
    • Mar 06, 2023: Catalent Appoints Sridhar Krishnan to Lead New Global Operational Excellence Strategy, "The Catalent Way"
    • Feb 27, 2023: BioMarin Announces Record Fourth Quarter and Full Year 2022 Results
    • Feb 27, 2023: Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
    • Feb 27, 2023: CELLINK and Nanyang Technological University Jointly Open a Research, Innovation and Development Lab Focused On Exploring Bioprinting in Critical Use Cases Like Regenerative Medicine and Drug Discovery
    • Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
    • Feb 21, 2023: Clearside Biomedical announces positive data presentations on CLS-AX OASIS clinical trial and use of SCS Microinjector presented at the Angiogenesis and Macula Society Annual Meetings
    • Feb 21, 2023: Halozyme Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
    • Feb 16, 2023: West Announces Fourth-Quarter and Full-Year 2022 Results
    • Feb 16, 2023: Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch
    • Feb 15, 2023: Viatris to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
    • Feb 14, 2023: CELLINK Introduces DNA Studio 4 Vault, a Bioprinting Software Developed to Support Our Customers to Adhere to Title 21 CFR Part 11 Electronic Records and EudraLex - Volume 4 – Good Manufacturing Practice (GMP) Guidelines - Chapter 4: Documentation
    • Feb 09, 2023: Palette Life Sciences announces publication of Barrigel pivotal safety and efficacy clinical trial data in JAMA Oncology
    • Feb 09, 2023: Fuji Pharma Co. Announces Consolidated financial results for the first quarter of the fiscal year ending September 30, 2023
    • Feb 09, 2023: Pfizer Announces Appointment of Meenakshi Nevatia as the Managing Director
    • Feb 06, 2023: Halozyme Appoints Barbara Duncan to its Board of Directors
    • Feb 06, 2023: Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023
    • Jan 29, 2023: JEXT pre-filled epinephrine auto-injector was granted approval for Guangdong-Hong Kong-Macao Greater Bay Area Imported Pharmaceuticals for urgent clinical needs in Mainland China
    • Jan 25, 2023: Dr Reddy's Laboratories Announces Unaudited Financial Results for the quarter and nine months ended December 31, 2022
    • Jan 24, 2023: BD to highlight its deep commitment to drug delivery innovation at Pharmapack
    • Jan 19, 2023: BioCorRx announces completion of treatment phase of study subjects and preliminary safety data from phase I clinical trial of BICX104, an implantable Naltrexone Pellet for the treatment of opioid use disorder
    • Jan 18, 2023: FDA Grants Priority Review for Nalmefene Prefilled Syringe for the treatment of known or suspected opioid overdos
    • Jan 17, 2023: N4 Pharma : Oral application update
    • Jan 17, 2023: Coming in From the Cold: Needle-free Patch Technology for mRNA Vaccines Aims to End Need for Frozen Storage and Improve Access
    • Jan 12, 2023: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
    • Jan 10, 2023: Emergent Lays off 132 employees
    • Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
    • Jan 05, 2023: Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors
    • Jan 04, 2023: SURGE Therapeutics receives FDA clearance of IND application to initiate phase 1/2a study of intraoperative immunotherapy in bladder cancer
    • Dec 29, 2022: Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
    • Dec 26, 2022: Sunovion Plans To Lay Off 360 Employees in 2023
  • Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

$4,000
$8,000
$12,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings